NDAQ Stock Recent News

HOUSTON, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it has closed its previously announced private placement priced at-the-market under Nasdaq rules for the issuance and sale of an aggregate of 4,597,702 shares of its common stock (or common stock equivalents in lieu thereof), series A warrants to purchase up to 6,407,657 shares of common stock and short-term series B warrants to purchase up to 6,407,657 shares of common stock at a purchase price of $0.87 per share of common stock (or per common stock equivalent in lieu thereof) and accompanying warrants in a private placement. The series A warrants and short-term series B warrants have an exercise price of $1.00 per share and will be exercisable beginning on the effective date of s

SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted non-qualified stock option awards to purchase an aggregate of 258,800 shares of its common stock to twenty-seven new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).

NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) --  The Nasdaq Stock Market announced today that it will delist the common stock of Gamer Pakistan Inc. Gamer Pakistan Inc.'s securities were suspended on August 5, 2024, and have not traded on Nasdaq since that time.

Announcement comes ahead of the first anniversary of Nasdaq's acquisition of Adenza Nasdaq also wins two awards for its financial crime management and regulatory reporting technology NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced it has jumped to 5th place in Chartis' annual RiskTech100® global ranking and has won two awards for its financial crime management and regulatory reporting technology. The news comes less than a year after Nasdaq's acquisition of Adenza and the establishment of its Financial Technology division.

NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of September 30, 2024, short interest in 3,067 Nasdaq Global MarketSM securities totaled 12,246,444,747 shares compared with 12,241,625,467 shares in 3,057 Global Market issues reported for the prior settlement date of September 13, 2024. The mid-September short interest represents 2.94 days compared with 3.06 days for the prior reporting period.

MCLEAN, Va. , Oct. 9, 2024 /PRNewswire/ -- Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") today provided an update on its delinquent filings and process for regaining compliance with Nasdaq listing requirements.

BEDFORD, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions, today announced that it has agreed to grant inducement awards to its newly appointed Chief Legal Officer, Todd D.C. Anderman. The awards were made as inducements material to Mr. Anderman's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).

Alternus Clean Energy Inc (NASDAQ:ALCE, OTC:ACLEW) announced that it will be implementing a 1-for-25 reverse stock split as part of its efforts to regain compliance with the $1 minimum bid price requirement for the Nasdaq Capital Market. It is expected the company's stock will start trading on a post-split basis at the opening of the market on October 11 under its existing ticker symbol “ALCE.

Company Rings Opening Bell to Celebrate Closure of Business Combination and Begins Journey as a Public Company; Shares trade under "BDMD" Ticker FORT MILL, S.C. , Oct. 9, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd.

SOUTH SAN FRANCISCO, Calif. & SANTA MONICA, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development of groundbreaking therapies for psychiatric disorders based on nose-to-brain neurocircuitry, and The Goldie Hawn Foundation's MindUP, a neuroscience-based preventative mental health program for youth, along with children from New York City schools utilizing MindUP, will join together in New York City on Oc.